Conmed (CNMD) Tops Q1 EPS by 9c; Raises Outlook

Conmed (NASDAQ: CNMD) reported Q1 EPS of $0.53, $0.09 better than the analyst estimate of $0.44. Revenue for the quarter came in at $202.1 million versus the consensus estimate of $196.4 million.

GUIDANCE:

Conmed raises FY2018 EPS to $2.15-$2.20, versus the consensus of $2.14.

For earnings history and earnings-related data on Conmed (CNMD) click here.

You May Also Be Interested In

• DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
• Smith-Midland Corporation (SMID) Tops Q2 EPS by 26c
• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown